EDP-494

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameEDP-494
Drug Alias NameEDP-494
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin B inhibitorsCyclophilin A inhibitors
TargetsCyclophilin ACyclophilin B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnanta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A